Does anyone know company what Oxford Club is touting as ‘the inventor of the world’s first AI-designed drug to enter clinical trials’? The next Intuitive Surgical?

The company is tiny today – just $500 million – but it is in position to grow dramatically.

More info from ad:
And big pharma is lining up to use its patent-protected technology. Merck is collaborating with them on three projects that could generate up to $674 million in revenue. French pharma giant Sanofi agreed to pay the company up to $5.2 billion to develop 15 new drugs. Bristol Meyers Squibb signed a $1.2 billion partnership with the company. You can see… each one of these projects is worth more than the entire market cap of this new AI stock!

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.